Universal Disease Mechanism Families (ch17 Supporting Literature)
1 López-Otín et al. 2023 — Hallmarks of Aging: An Expanding Universe
Full Citation:: López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243–278. López-Otín et al. (2023) DOI:: 10.1016/j.cell.2022.11.001 PMID:: 36599349 Study Design:: Landmark expert review expanding the hallmarks-of-aging framework Key Findings::
- Expands the 2013 hallmarks-of-aging framework from 9 to 12 hallmarks
- Three new hallmarks added: disabled macroautophagy, chronic inflammation (inflammaging), and dysbiosis
- Hallmarks 1--12 include: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, dysbiosis
- Describes mechanistic interdependencies and cross-talk between hallmarksRelevance to ch17:: Closest published taxonomy to the 19-family universal mechanism framework. Hallmarks map directly onto ch17 families 1, 2, 12, 13, 14, 9, 4, 15. Limitations:: Focused on aging biology; does not address acute disease, infectious, or structural-integrity mechanisms. Certainty Assessment::
- *Quality:* High (Cell landmark review, 5 senior authors)
- *Replication:* Framework widely adopted and validated
- *Score:* 0.952 Gorman/Hwang et al. 2023 — WASF3 Disrupts Mitochondrial Respiratory Complex Assembly in ME/CFS
Full Citation:: Hwang YS et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. PNAS. 2023;120(34):e2302738120. (Hwang et al. 2023) DOI:: 10.1073/pnas.2302738120 PMID:: 37579159 Key Findings::
- ER stress-induced WASF3 localises to mitochondria, disrupts respiratory supercomplex assembly
- Reduces oxygen consumption and exercise endurance in vivo
- ME/CFS skeletal muscle biopsies: elevated WASF3 and aberrant ER stressRelevance to ch17:: Family 1 (energy/metabolic); links ER stress (Family 13) to OXPHOS failure. Single NIH group finding. Certainty Assessment::
- *Quality:* High (PNAS, NIH)
- *Replication:* Not yet independently replicated
- *Score:* 0.603 Fluge and Mella et al. 2017 — Metabolic Profiling Indicates Impaired PDH Function in ME/CFS
Full Citation:: Fluge Ø, Mella O, Bruland O, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2017;1(21):e89376. (Fluge et al. 2017) DOI:: 10.1172/jci.insight.89376 PMID:: 28018972 Study Design:: Case-control metabolomics + PBMC gene expression; n=200 ME/CFS, 102 controls Key Findings::
- Amino acid depletion pattern consistent with PDH impairment
- PDK1 (p=0.002), PDK2 (p=0.022), PDK4 (p=0.006) mRNA upregulated in PBMCs; SIRT4 upregulated (p=0.013)
- Myoblasts in ME/CFS serum: increased mitochondrial respiration + excess lactateRelevance to ch17:: Central evidence for PDK upregulation in Family 1. Certainty Assessment::
- *Quality:* High (JCI Insight, n=200)
- *Replication:* PDK block partially replicated; Bergen group
- *Score:* 0.804 Rajeevan et al. 2018 — ME/CFS Associated with Premature Telomere Attrition
Full Citation:: Rajeevan MS, Murray J, Oakley LP, Lin J-MS, Unger ER. Association of chronic fatigue syndrome with premature telomere attrition. J Transl Med. 2018;16(1):44. (Rajeevan et al. 2018) DOI:: 10.1186/s12967-018-1414-x PMID:: 29486769 Study Design:: Cross-sectional; 639 participants from Georgia CFS surveillance study (CDC) Key Findings::
- Telomeres 254--957 bp shorter in CFS vs non-fatigued controls (equivalent 4--20 years added aging)
- Association strongest in women under 45Relevance to ch17:: Family 12 (genomic/epigenetic). ch17 key (Rajeevan et al. 2018) is an alias for this paper. Certainty Assessment::
- *Quality:* Medium (CDC cohort, cross-sectional, n=639)
- *Replication:* Single cohort study; consistent with broader chronic-disease accelerated-aging literature
- *Score:* 0.605 Ayres 2020 — The Biology of Physiological Health
Full Citation:: Ayres JS. The biology of physiological health. Cell. 2020;181(2):250–269. (Ayres 2020) DOI:: 10.1016/j.cell.2020.03.029 PMID:: 32302569 Key Findings::
- Body responds to diverse insults via a finite set of tolerance and resistance pathways
- Physiological health involves active evolved mechanisms distinct from disease pathogenesisRelevance to ch17:: Theoretical support for the finite-mechanisms framing in ch17 opening. Cited with (Quintero 2014). Certainty Assessment::
- *Quality:* High (Cell Perspectives)
- *Score:* 0.856 Sasso et al. 2026 — Large-Scale Confirmation of TRPM3 Ion Channel Dysfunction in ME/CFS
Full Citation:: Sasso EM, Er TS, Eaton-Fitch N, Hool L, Muraki K, Marshall-Gradisnik S. Large-scale investigation confirms TRPM3 ion channel dysfunction in ME/CFS. Frontiers in Medicine. 2026;12:1703924. (Sasso et al. 2026) DOI:: 10.3389/fmed.2025.1703924 Study Design:: Multi-site; whole-cell patch-clamp; 36 ME/CFS, 42 controls; two independent laboratories Key Findings::
- Confirms reduced TRPM3 current in ME/CFS NK cells across two independent labs
- Supports TRPM3 as candidate diagnostic biomarkerRelevance to ch17:: Primary large-scale replication for Family 3. ch17 key (Sasso et al. 2026). Certainty Assessment::
- *Quality:* High (multi-site, two independent labs)
- *Replication:* Replicated; builds on 5+ prior Griffith studies
- *Score:* 0.807 Gottschalk et al. 2022 — ATG13 Drives Microglial Oxidative Stress via RAGE in ME/CFS
Full Citation:: Gottschalk CG, Peterson D, Knox K, Maynard M, Whelan RJ. Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE). Mol Cell Neurosci. 2022;120:103731. (Gottschalk et al. 2022) DOI:: 10.1016/j.mcn.2022.103731 PMID:: 35487443 Key Findings::
- ATG13 elevated in ME/CFS serum; induces ROS + NO in HMC3 microglial cells via RAGE
- ATG13 neutralisation reduces microglial oxidative stressRelevance to ch17:: Family 13 (autophagy block) linked to Family 10 (neuroinflammation). ch17 key (Gottschalk et al. 2022). Certainty Assessment::
- *Quality:* Medium-high (mechanistic ex vivo, peer-reviewed)
- *Replication:* ATG13 elevation replicated; RAGE mechanism single group
- *Score:* 0.658 Kavyani et al. 2022 — Kynurenine Pathway as the Key Missing Piece of ME/CFS
Full Citation:: Kavyani B et al. Could the kynurenine pathway be the key missing piece of ME/CFS complex puzzle? Cell Mol Life Sci. 2022;79(8):412. (Kavyani et al. 2022) DOI:: 10.1007/s00018-022-04380-5 PMID:: 35821534 Key Findings::
- IDO1/IDO2 diverts tryptophan to kynurenine → reduces NAD+ → impairs mitochondrial energy
- Neurotoxic kynurenine metabolites contribute to neuroinflammation
- Integrates Families 4, 11, and 1Relevance to ch17:: Family 11 (amino acid/neurotransmitter metabolism). ch17 key (Kavyani et al. 2022). Certainty Assessment::
- *Quality:* Medium (review, Cellular and Molecular Life Sciences)
- *Score:* 0.659 Nunes et al. 2024 — Proteomics Reveals Coagulation and Endothelial Dysfunction in ME/CFS
Full Citation:: Nunes JM, Vlok M, Proal A, Kell DB, Pretorius E. Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction. Cardiovasc Diabetol. 2024;23(1):254. (Nunes et al. 2024) DOI:: 10.1186/s12933-024-02315-x Study Design:: DIA LC-MS/MS proteomics; 15 ME/CFS, 10 controls Key Findings::
- 24 proteins elevated (thrombospondin-1, platelet factor 4, protein S); 21 downregulated (complement)
- Supports dysregulated coagulation + endothelial dysfunctionRelevance to ch17:: Families 6 and 7. ch17 key (Nunes et al. 2024). Certainty Assessment::
- *Quality:* Medium (n=15; single group)
- *Score:* 0.6010 Saha, Krishnan & Raghu 2023 — IMPA1-Dependent PIP2 and Ca2+ Signalling by Lithium
Full Citation:: Saha S, Krishnan H, Raghu P. IMPA1 dependent regulation of phosphatidylinositol 4,5-bisphosphate and calcium signaling by lithium. Life Sci Alliance. 2023;7(2):e202302425. (Saha, Krishnan, and Raghu 2023) DOI:: 10.26508/lsa.202302425 PMID:: 38056909 Study Design:: Mechanistic; HEK293T WT + CRISPR IMPA1 KO; human iPSC-derived forebrain cortical neurons (DIV45) Key Findings::
- 1 mM Li+ slows PIP2 resynthesis after PLC activation; absent in IMPA1 KO cells (causal proof)
- Li+ reduces receptor-activated ER Ca2+ release in IMPA1-dependent manner
- Human cortical neurons: reduced Ca2+ transient frequency + diminished excitability after Li+
- GSK-3beta inhibition does not replicate these effects: IMPA1 is the primary route
- Transcriptomics: enrichment in glutamatergic + Ca2+ signaling pathwaysRelevance:: Direct mechanistic evidence for Li+ to IMPase to reduced PIP2 pool to attenuated IP3-mediated Ca2+ release. Primary support for paragraph addition to Lithium Safety: Drug Interactions and Contraindications (ch08). Also relevant to pip2 exhaustion (ch14h). Certainty Assessment::
- *Quality:* Medium-High (Life Science Alliance; CRISPR KO controls; iPSC human neurons)
- *Score:* 0.62
- *Limitation:* Cell model only; single group (NCBS, India); no animal or clinical data11 Schlecker et al. 2006 — NCS-1 Enhancement of InsP3R1 Inhibited by Lithium
Full Citation:: Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, Szigeti-Buck K, Ehrlich BE. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest. 2006;116(6):1668–1674. (Schlecker et al. 2006) DOI:: 10.1172/JCI22466 PMID:: 16691292 Study Design:: Mechanistic; rat brain tissue; PC12 cells; planar lipid bilayers with purified InsP3R1 + NCS-1 protein; n>=3 bilayer experiments, n>=10 Ca2+ imaging experiments Key Findings::
- NCS-1 increases InsP3R1 open probability approximately 5-fold (4% to 21%)
- Li+ IC50 approximately 350 uM (within therapeutic plasma range) attenuates NCS-1/InsP3R1 association
- Therapeutic Li+ significantly reduces NCS-1-mediated Ca2+ release in intact cells
- Effect specific to InsP3R1; no effect on ryanodine receptor type 2Relevance:: Second route by which Li+ dampens IP3-mediated ER Ca2+ release – independent of IMPase. Relevant wherever NCS-1 is elevated (bipolar disorder, schizophrenia; conceivably ME/CFS neuronal tissue). Certainty Assessment::
- *Quality:* High (Journal of Clinical Investigation; rigorous bilayer + cell validation)
- *Score:* 0.65
- *Limitation:* Rat and cell model; IC50 near upper limit of clinical Li+ plasma range12 Boeckel & Ehrlich 2018 — NCS-1 as Regulator of Ca2+ Signaling in Health and Disease
Full Citation:: Boeckel GR, Ehrlich BE. NCS-1 is a regulator of calcium signaling in health and disease. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt B):1660–1667. (Boeckel and Ehrlich 2018) DOI:: 10.1016/j.bbamcr.2018.05.005 PMID:: 29746899 Study Design:: Review Key Findings::
- NCS-1 modulates InsP3R by increasing InsP3-gated channel activity without altering single-channel amplitude
- Li+ and ibudilast both reduce overexpressed NCS-1 effects
- NCS-1 implicated in bipolar disorder, schizophrenia, autism, and chemotherapy-induced peripheral neuropathyRelevance:: Contextualises NCS-1/IP3R as a broadly disease-relevant regulatory axis; reinforces Li+ to NCS-1 to IP3R dampening as a general mechanistic principle extending beyond bipolar disorder. Certainty Assessment::
- *Quality:* Medium (review; Biochimica et Biophysica Acta)
- *Score:* 0.5513 Nguyen et al. 2019 — Structural Basis of NCS-1/InsP3R1 Interaction
Full Citation:: Nguyen LD, Petri ET, Huynh LK, Ehrlich BE. Characterization of NCS1–InsP3R1 interaction and its functional significance. J Biol Chem. 2019;294(49):18923–18933. (Nguyen et al. 2019) DOI:: 10.1074/jbc.RA119.009736 PMID:: 31659121 Study Design:: Mechanistic; MDA-MB231 + HEK293 cells; mouse cerebellum; protein docking using crystal structures Key Findings::
- NCS-1 binding site mapped to residues 66--110 on InsP3R1 suppressor domain
- Leu-89 on NCS-1 is critical; mutations at this position abolish Ca2+ signaling enhancement
- EC50 for interaction approximately 160 nM Ca2+ (physiologically relevant submicromolar range)
- Cell-penetrant blocking peptides reduce InsP3R-dependent Ca2+ signaling in live cellsRelevance:: Provides structural basis for NCS-1/IP3R amplification that Li+ disrupts. Confirms the interaction has a defined and potentially targetable binding interface. Certainty Assessment::
- *Quality:* Medium-High (Journal of Biological Chemistry; rigorous binding-site mapping)
- *Score:* 0.62
- *Limitation:* Breast cancer cell line + docking; limited primary neuronal data14 Sade et al. 2016 — IP3 Accumulation and/or Inositol Depletion as Lithium’s Downstream Effects
Full Citation:: Sade Y, Toker L, Kara NZ, Einat H, Rapoport S, Moechars D, Berry GT, Bersudsky Y, Agam G. IP3 accumulation and/or inositol depletion: two downstream lithium’s effects that may mediate its behavioral and cellular changes. Transl Psychiatry. 2016;6(12):e968. (Sade et al. 2016) DOI:: 10.1038/tp.2016.217 PMID:: 27922641 Study Design:: Mouse behavioral models; SMIT1 KO + IMPA1 KO; forced swim + locomotor assays; hippocampal molecular analysis Key Findings::
- IP3 (not IP1) reduces immobility in forced swim by approximately 30%; reversed by IP3R antagonists
- SMIT1 KO (60% reduced brain inositol) and IMPA1 KO both phenocopy Li+ behaviorally
- IP3 treatment increases autophagy (Beclin-1/p62 ratio approximately 3-fold), paralleling Li+
- Both pathways (IP3 accumulation AND inositol depletion) contribute independentlyRelevance:: Establishes that IMPA1 inhibition to IP3 accumulation is behaviorally and molecularly significant. Supports interpretation that chronic GPCR-driven IP3 accumulation in ME/CFS (from the PIP2 exhaustion hypothesis) could be pathological, and Li+ moderates it. Certainty Assessment::
- *Quality:* Medium (Translational Psychiatry; mouse models; limited human translation)
- *Score:* 0.6215 Harwood 2005 — Lithium and Bipolar: Inositol-Depletion Hypothesis Revisited
Full Citation:: Harwood AJ. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry. 2005;10(1):117–126. (Harwood 2005) DOI:: 10.1038/sj.mp.4001618 PMID:: 15558078 Study Design:: Review Key Findings::
- Li+ reduces cellular myo-inositol and attenuates PLC-downstream signaling
- Full PI cycle covered: IMPase to inositol to PIP2 to PLC to IP3 to Ca2+
- Hypothesis contested: clinical studies inconsistent on brain inositol reduction in vivo
- 35+ years of supporting biochemical evidence summarisedRelevance:: Foundational review and critical appraisal for the Li+ to IMPase to inositol to PIP2 chain. Acknowledged uncertainty supports keeping this content in a speculation environment. Certainty Assessment::
- *Quality:* Medium (Molecular Psychiatry review; high-impact but no primary data)
- *Score:* 0.5516 Belmaker et al. 1998 — Behavioral Reversal of Lithium by Inositol Isomers
Full Citation:: Belmaker RH, Agam G, van Calker D, Richards MH, Kofman O. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle. Neuropsychopharmacology. 1998;19(3):220–232. (Belmaker et al. 1998) DOI:: 10.1016/S0893-133X(98)00017-7 PMID:: 9653710 Study Design:: Rat behavioral + biochemical; human postmortem brain inositol measurement Key Findings::
- Four inositol isomers (including unnatural epi-inositol) reverse Li+ behavioral effects; correlations perfect with PI cycle biochemistry
- Chronic Li+ brain inositol depletion specific to hypothalamus
- Postmortem bipolar frontal cortex: 25% reduced inositol vs. controls
- Stereospecific reversal by myo-inositol (not D-chiroinositol) in pilocarpine seizure modelRelevance:: Classical causal evidence linking inositol depletion to Li+ behavioral mechanism. Stereospecificity is strong evidence for the PI cycle pathway. Inositol supplementation reversal is a testable prediction for the speculation environment. Certainty Assessment::
- *Quality:* Medium (Neuropsychopharmacology; rat + postmortem; 1998)
- *Score:* 0.5817 Yu & Greenberg 2016 — Inositol Depletion, GSK3 Inhibition and Bipolar Disorder
Full Citation:: Yu W, Greenberg ML. Inositol depletion, GSK3 inhibition and bipolar disorder. Future Neurol. 2016;11(2):135–148. (Yu and Greenberg 2016) DOI:: 10.2217/fnl-2016-0003 PMID:: 29339929 Study Design:: Review Key Findings::
- Li+ inhibits IMPase; valproate inhibits MIPS activity via GSK3 -- both reduce brain inositol
- GSK3 regulates MIPS phosphorylation; GSK3 inhibition reduces inositol synthesis
- Inositol depletion and GSK3 inhibition are synergistic (not alternative) mechanisms of Li+Relevance:: Connects the two major Li+ mechanisms (IMPase inhibition and GSK3 inhibition, already in Lithium Safety: Drug Interactions and Contraindications) as convergent routes to inositol/PIP2 reduction. Unifies the existing and new speculative paragraphs in ch08. Certainty Assessment::
- *Quality:* Low-Medium (Future Neurology; lower-tier review journal)
- *Score:* 0.5018 Palomo et al. 2026 — Chronic Herpesvirus Reactivation in Post-Infectious ME/CFS
Full Citation:: Palomo A, Cox B, Williams M, Ariza ME. Chronic reactivation of persistent herpesviruses EBV, HHV-6 and VZV in post-infectious ME/CFS. J Med Virol. 2026;98:e70769. (Palomo et al. 2026) DOI:: 10.1002/jmv.70769 PMID:: 41451845 Study Design:: Longitudinal serology; 40 ME/CFS (873 samples), 16 controls (378 samples) Key Findings::
- 72.5% ME/CFS patients elevated anti-EBV dUTPase IgG; also elevated anti-HHV-6 and anti-VZV IgG
- Antibody levels correlate with fatigue severityRelevance to ch17:: Family 16 (viral persistence/immune evasion). Certainty Assessment::
- *Quality:* Medium (n=40, Journal of Medical Virology)
- *Score:* 0.65